ABOUT CITRINE S A L

Citrine S A L is a leading technology-focused investment group that enables Israeli entrepreneurs to materialize global breakthrough technology companies.

Citrine technology funds include the management of Limited Partnerships by Citrine S A L  High-Tech and Citrine S A L Biotech that operate as Managing Partners.

The partnerships are registered as Limited Partnerships with the Registrar of Partnerships in Israel and include a variety of options for investment periods, fields of expertise, risk levels, profitability levels and protections that allow the investor to diversify his investment and minimize risk.

 

Citrine Global Corp. (OTCQB: CTGL):

Citrine Global, Corp. (OTCQB: CTGL) (“Citrine Global”) develops strategic solutions for technology industries with global growth potential in the high-tech and biotech fields, which include supportive environments that combine, among other things, entrepreneurship and the establishment of innovation centers for production, operations, R&D, marketing, export, assistance in building strategy for realizing the potential, and more.

וולת'סטון PRIVET EQUITY.png

Our focus areas: 

  • medical devices

  • digital health

  • cannabis technologies

  • wellness solutions

  • personalized medicine

  • block chain solutions 

  • biotechnology

  • diagnosis/prevention

  • clean-tech

  • green energy

  • cyber technology

  • Media

  • Internet of Things

Citrine is part of:

WealthStone Group, that specializes in Alternative Investment in various fields , Hedge Funds , Real-estate and Technology

​• Neto Finance , one of the largest insurance & finance adviser firms in Israel managing 7B NIS for private client & investors.

 

In the past 5 years, the group has raised over $300M from Israeli private investors setting up ~70 partnerships in various fields.

The group targets to manage in the next 7 years  $1B Dollar for private & international investors.

Globalization concept